BioMarin Pharmaceutical
BMRN
#1907
Rank
โ‚ฌ8.81 B
Marketcap
45,87ย โ‚ฌ
Share price
-0.78%
Change (1 day)
-27.39%
Change (1 year)

Earnings for BioMarin Pharmaceutical (BMRN)

Earnings in 2025 (TTM): โ‚ฌ0.61 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's current earnings are โ‚ฌ3.09 Billion. In 2024 the company made an earning of โ‚ฌ0.46 Billion, an increase over its 2023 earnings that were of โ‚ฌ0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioMarin Pharmaceutical from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚ฌ0.61 B31.81%
2024 โ‚ฌ0.46 B187.31%
2023 โ‚ฌ0.16 B26.07%
2022 โ‚ฌ0.12 B-298.51%
2021 -โ‚ฌ64.72 Million78.04%
2020 -โ‚ฌ36.36 Million-55.36%
2019 -โ‚ฌ81.44 Million-33.56%
2018 -โ‚ฌ0.13 Billion297.78%
2017 -โ‚ฌ30.82 Million-95.68%
2016 -โ‚ฌ0.72 Billion437.12%
2015 -โ‚ฌ0.14 Billion23.91%
2014 -โ‚ฌ0.11 Billion-29.25%
2013 -โ‚ฌ0.16 Billion49.23%
2012 -โ‚ฌ0.11 Billion171.11%
2011 -โ‚ฌ37.48 Million103.01%
2010 -โ‚ฌ18.46 Million-3903.54%
2009 โ‚ฌ0.48 M-98.31%
2008 โ‚ฌ28.7 M-189.7%
2007 -โ‚ฌ32.01 Million51.02%
2006 -โ‚ฌ21.2 Million-61.58%
2005 -โ‚ฌ55.16 Million-56.59%
2004 -โ‚ฌ0.13 Billion95.13%
2003 -โ‚ฌ65.11 Million12.09%
2002 -โ‚ฌ58.09 Million73.19%
2001 -โ‚ฌ33.54 Million18.32%
2000 -โ‚ฌ28.35 Million19.65%
1999 -โ‚ฌ23.7 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ultragenyx Pharmaceutical
RARE
-โ‚ฌ0.45 Billion-176.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-โ‚ฌ93.65 Million-116.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚ฌ23.57 Million-104.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ7.81 B 1,239.71%๐Ÿ‡ซ๐Ÿ‡ท France
Amicus Therapeutics
FOLD
โ‚ฌ4.27 M-99.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
โ‚ฌ0.24 B-57.93%๐Ÿ‡บ๐Ÿ‡ธ USA